As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines. The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making. ROLE SUMMARY The HTA, Value & Evidence Senior Manager is responsible for development and execution of high-quality HV&E strategic efforts to support optimal access and reimbursement for treatments in Rare Disease. This role directly impacts business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of Rare Disease medicines. This position will be part of Pfizer’s dynamic US Medical Affairs/HV&E team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to Rare Disease with a primary focus on Hympavzi/Vyndaqel and SCD. This position will be working closely with cross-functional teams (e.g., access, medical, clinical, commercial, etc.) to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general. This position will function in a closely aligned fashion with the Access team to ensure there is a single and coordinated view on strategy and project execution. This position will function with a One Pfizer mindset and will be expected to partner with Pfizer colleagues in various regional and national markets to ensure a consistent and robust evidence generation strategy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior